Hyperphosphatemia aggravates cardiac fibrosis and microvascular disease in experimental uremia.

@article{Amann2003HyperphosphatemiaAC,
  title={Hyperphosphatemia aggravates cardiac fibrosis and microvascular disease in experimental uremia.},
  author={Kerstin Amann and Johannes T{\"o}rnig and Birgit Kugel and Marie-Luise Gro\ss and Karin Tyralla and Abdussalam El-Shakmak and Andr{\'a}s Szab{\'o} and Eberhard Ritz},
  journal={Kidney international},
  year={2003},
  volume={63 4},
  pages={1296-301}
}
BACKGROUND Hyperphosphatemia is a known predictor of cardiovascular death and specifically of cardiac death in hemodialysis patients. The pathomechanisms involved have not been completely clarified. While a number of observations suggest an important role of hyperphosphatemia and positive calcium balance on atherosclerosis and calcification of the coronary conduit arteries, independent effects on postcoronary microvessels and on cardiac fibrosis have not been excluded. METHODS Male Sprague… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 65 extracted citations

The calcimimetic AMG 641 accelerates regression of extraosseous calcification in uremic rats.

American journal of physiology. Renal physiology • 2009
View 14 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…